284 related articles for article (PubMed ID: 29644333)
1. Risk of transplanting malignant cells in cryopreserved ovarian tissue.
Dolmans MM; Masciangelo R
Minerva Ginecol; 2018 Aug; 70(4):436-443. PubMed ID: 29644333
[TBL] [Abstract][Full Text] [Related]
2. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue.
Dolmans MM; Luyckx V; Donnez J; Andersen CY; Greve T
Fertil Steril; 2013 May; 99(6):1514-22. PubMed ID: 23541406
[TBL] [Abstract][Full Text] [Related]
3. Safety of ovarian tissue transplantation in patients with borderline ovarian tumors.
Masciangelo R; Bosisio C; Donnez J; Amorim CA; Dolmans MM
Hum Reprod; 2018 Feb; 33(2):212-219. PubMed ID: 29281007
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence.
Kristensen SG; Giorgione V; Humaidan P; Alsbjerg B; Bjørn AB; Ernst E; Andersen CY
Fertil Steril; 2017 May; 107(5):1206-1213. PubMed ID: 28433369
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients.
Dolmans MM; Iwahara Y; Donnez J; Soares M; Vaerman JL; Amorim CA; Poirel H
Hum Reprod; 2016 Oct; 31(10):2292-302. PubMed ID: 27591237
[TBL] [Abstract][Full Text] [Related]
6. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
[TBL] [Abstract][Full Text] [Related]
7. Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma.
Sørensen SD; Greve T; Wielenga VT; Wallace WH; Andersen CY
Future Oncol; 2014 Feb; 10(2):277-83. PubMed ID: 24490613
[TBL] [Abstract][Full Text] [Related]
8. Challenges of fertility preservation in leukemia patients.
Shapira M; Raanani H; Derech Chaim S; Meirow D
Minerva Ginecol; 2018 Aug; 70(4):456-464. PubMed ID: 29696942
[TBL] [Abstract][Full Text] [Related]
9. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature.
Rosendahl M; Greve T; Andersen CY
J Assist Reprod Genet; 2013 Jan; 30(1):11-24. PubMed ID: 23263841
[TBL] [Abstract][Full Text] [Related]
10. Cryostorage and retransplantation of ovarian tissue as an infertility treatment.
Amorim CA; Leonel ECR; Afifi Y; Coomarasamy A; Fishel S
Best Pract Res Clin Endocrinol Metab; 2019 Feb; 33(1):89-102. PubMed ID: 31208678
[TBL] [Abstract][Full Text] [Related]
11. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria.
Meirow D; Ra'anani H; Shapira M; Brenghausen M; Derech Chaim S; Aviel-Ronen S; Amariglio N; Schiff E; Orvieto R; Dor J
Fertil Steril; 2016 Aug; 106(2):467-74. PubMed ID: 27181924
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of cryopreserved ovarian tissue in a patient affected by metastatic struma ovarii and endometriosis.
Fabbri R; Vicenti R; Paradisi R; Rossi S; De Meis L; Seracchioli R; Macciocca M
Gynecol Endocrinol; 2018 Jul; 34(7):558-562. PubMed ID: 29318892
[TBL] [Abstract][Full Text] [Related]
13. Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients.
Soares M; Saussoy P; Maskens M; Reul H; Amorim CA; Donnez J; Dolmans MM
Br J Haematol; 2017 Jul; 178(2):231-239. PubMed ID: 28419412
[TBL] [Abstract][Full Text] [Related]
14. Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation.
Hoekman EJ; Louwe LA; Rooijers M; van der Westerlaken LAJ; Klijn NF; Pilgram GSK; de Kroon CD; Hilders CGJM
Acta Obstet Gynecol Scand; 2020 Feb; 99(2):213-221. PubMed ID: 31538662
[TBL] [Abstract][Full Text] [Related]
15. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination.
Shapira M; Raanani H; Barshack I; Amariglio N; Derech-Haim S; Marciano MN; Schiff E; Orvieto R; Meirow D
Fertil Steril; 2018 Jan; 109(1):48-53. PubMed ID: 29198847
[TBL] [Abstract][Full Text] [Related]
16. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births.
Donnez J; Silber S; Andersen CY; Demeestere I; Piver P; Meirow D; Pellicer A; Dolmans MM
Ann Med; 2011; 43(6):437-50. PubMed ID: 21226660
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases.
Jadoul P; Guilmain A; Squifflet J; Luyckx M; Votino R; Wyns C; Dolmans MM
Hum Reprod; 2017 May; 32(5):1046-1054. PubMed ID: 28333228
[TBL] [Abstract][Full Text] [Related]
18. Techniques for ovarian tissue transplantation and results.
Donnez J; Manavella DD; Dolmans MM
Minerva Ginecol; 2018 Aug; 70(4):424-431. PubMed ID: 29644328
[TBL] [Abstract][Full Text] [Related]
19. [Ovarian tissue cryopreservation in girls].
Poirot C; Guerin F; Yakouben K; Prades M; Martelli H; Brugieres L
Bull Acad Natl Med; 2013; 197(4-5):887-98. PubMed ID: 25518157
[TBL] [Abstract][Full Text] [Related]
20. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
